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Alternatively, KIF5C or other axon motors can trans-
port signaling molecules such as GSK3b, Rap1B, and
CRMP2 to the axonal growth cone and then promote
the specification of axons. Two lines of evidences sup-
port this idea. First, CRMP-2 mediates the transport
of some actin cytoskeleton regulators by Kinesin-1
(Kawano et al., 2005). Second, Par3 interacts with a Ki-
nesin-2 family member, KIF3A (Nishimura et al., 2004),
an interaction that is important for axon formation.
In summary, time-lapse imaging with live markers is
an important approach to dissect the molecular and cel-
lular mechanisms of axon specification. Even though
the functional significance of the dynamic variation of
KIF5C levels among stage 2 neurites (e.g., as a manifes-
tation of the competition among equivalent neurites to
become an axon) remains unclear, nevertheless, Jacob-
son and colleagues’ study revealed that there are fasci-
nating and not yet understood processes going on dur-
ing axon specification. Future studies should address
the nature of the biochemical differences between neu-
rites of unpolarized stage 2 neurons and why KIF5C pre-
fers one or two neurites in stage 2 and the presumptive
axon in stage 3 neurons.
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412Turning off Smads:
Identification of a
Smad Phosphatase
Although the activation of Smad signaling pathways
downstream of TGF-b superfamily ligands by recep-
tor-mediated Smad phosphorylation is well under-
stood, nothing is known about Smad phosphatases
that turn off Smad activity. Recently in Genes & Devel-
opment, Chen et al. (2006) describe pyruvate dehydro-
genase phosphatase as a Smad1 phosphatase that
functions in Drosophila in the Decapentaplegic path-
way and in mammalian cells in the BMP pathway.
Signals from transforming growth factor b (TGF-b)
family members are transduced from receptors at the
plasma membrane to the nucleus by members of the
Smad family. Broadly speaking, the receptor-regulated
Smads (R-Smads), Smads 2 and 3, function down-
stream of the TGF-b/Nodal/Activin ligands, while Smads
1, 5, and 8 are downstream of members of the bone
morphogenetic protein (BMP) and growth and differen-
tiation factor (GDF) subfamilies of ligands (Massague´
et al., 2005). Activation of cell surface receptors by li-
gands leads to phosphorylation of the R-Smads at
two serines in an SM/VS motif at their extreme C termini.
This phosphorylation allows the R-Smads to form both
homomeric and heteromeric complexes with Smad4that accumulate in the nucleus. There, they are directly
involved in transcriptional regulation of target genes in
cooperation with other transcription factors.
The initial view of the TGF-b superfamily pathways
was that they were linear and unidirectional, with Smad
phosphorylation causing translocation of Smad com-
plexes from the cytoplasm to the nucleus, where they
were degraded via a ubiquitin-regulated pathway (Lo
and Massague´, 1999). However, the first hint that Smads
were not only capable of being imported into the nucleus
but were also exported from it came from studies of
Smad4. Smad4 was demonstrated to be constantly
shuttling between the cytoplasm and nucleus in unstim-
ulated cells due to the presence of a nuclear import
signal and a nuclear export signal (Pierreux et al., 2000;
Watanabe et al., 2000). Smad1 was also shown to be ca-
pable of nucleocytoplasmic shuttling (Xiao et al., 2001).
Then in 2002, it was demonstrated that the TGF-b-regu-
lated R-Smads, Smad2 and Smad3, constantly shuttle
between the nucleus and the cytoplasm both in unin-
duced cells (Xu et al., 2002) and during TGF-b signaling,
where Smad nucleocytoplasmic shuttling was proposed
to function as a mechanism whereby the Smads moni-
tored receptor activity (Inman et al., 2002). Most impor-
tantly, nucleocytoplasmic Smad shuttling in the pres-
ence of a TGF-b signal appears to require cycles of
Smad phosphorylation and dephosphorylation. When
TGF-b receptor kinase activity is blocked in TGF-b-stim-
ulated cells, Smad2 becomes rapidly dephosphory-
lated, and Smad2 and Smad4 both redistribute from
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thermore, when Smad2 export was studied in vitro in
isolated permeabilized nuclei from TGF-b-induced
HeLa cells, the exported Smad2 was shown to be de-
phosphorylated (Xu et al., 2002). These results demon-
strated the existence of R-Smad phosphatases. Further
analysis of Smad nucleocytoplasmic shuttling has sug-
gested that such phosphatases might play important
roles in regulating both the duration and strength of
TGF-b superfamily signaling pathways (Schmierer and
Hill, 2005).
The identities of R-Smad phosphatases have re-
mained elusive until very recently, when Lan Xu and co-
workers reported that pyruvate dehydrogenase phos-
phatase (PDP) acts as a Smad1 phosphatase (Chen
et al., 2006). These authors performed a functional
screen in Drosophila S2 cells using double-stranded
RNAs (dsRNA) against all 44 Ser/Thr phosphatases in
theDrosophila genome. They focused on signaling in re-
sponse to the Drosophila BMP family member, Decap-
entaplegic (DPP), which activates the R-Smad, MAD
(mothers against DPP), which is most closely related to
mammalian Smad1. They measured dephosphorylation
of MAD upon washout of DPP ligand and identified PDP
as a phosphatase, which, when knocked down, allowed
sustained phosphorylation of MAD. To strengthen the
idea that PDP acts in the DPP pathway, they investi-
gated the level of phosphorylated MAD in a Drosophila
strain that harbors a piggyback transposon just up-
stream of the first exon of the PDP gene, and in another
strain that has a chromosome deletion that includes the
PDP gene. In both strains in stage 6 embryos, they ob-
served an expanded dorsal stripe of phosphorylated
MAD compared to wild-type embryos.
Since the receptors that phosphorylate MAD are
themselves activated by phosphorylation, knocking
down, mutating, or deleting a receptor phosphatase
would have the same effect on MAD phosphorylation
as knocking down, mutating, or deleting the MAD phos-
phatase. Chen et al. (2006) directly addressed this by
demonstrating that recombinant GST-PDP can effec-
tively and specifically dephosphorylate phosphorylated
MAD in vitro, and they also demonstrated a direct inter-
action between phosphorylated MAD and PDP. Finally,
these authors also provide evidence that the mamma-
lian PDPs, PDP1 and PDP2, are involved in dephosphor-
ylation of BMP-activated Smad1, but not of TGF-b-acti-
vated Smad2 and Smad3.
These very interesting findings now raise a number of
important questions. Is PDP the only C-terminal Smad1
phosphatase? In cells knocked down for PDP, MAD was
still dephosphorylated to some extent. What is the func-
tional relevance of pyruvate dehydrogenase phospha-
tase being a Smad1/MAD phosphatase? This is obvi-
ously not the first time an enzyme with a key role in
metabolism has been found to be involved in signal
transduction pathways; the best example to date is
GSK3, which was identified as a regulator of glycogen
metabolism and then discovered to play a key role
in Wnt signaling, as well as in many other cellular pro-
cesses (Frame and Cohen, 2001). To date, pyruvate de-hydrogenase phosphatase has been thought to reside
in the mitochondrial matrix, where it dephosphorylates
the pyruvate dehydrogenase complex, which
catalyzes the conversion of pyruvate to acetyl CoA.
Dephosphorylation reverses the inhibitory activity of py-
ruvate dehydrogenase kinase and reactivates the pyru-
vate dehydrogenase complex. PDP2 is transcriptionally
downregulated in rat heart and kidney during starvation
and diabetes. This reduces pyruvate dehydrogenase
activity and thus prevents tissues other than the brain
from catabolizing glucose (Huang et al., 2003). The pre-
diction might be that BMP signaling would be altered in
these tissues during starvation or diabetes. It will be
very interesting to see if this is the case. The involve-
ment of PDP in Smad signaling also suggests that it
functions outside of the mitochondria. Indeed, PDP-
GFP was not only found in mitochondria, but was dis-
tributed throughout the cell (Chen et al., 2006). It will
be important in the future to discover where dephos-
phorylation of MAD/Smad1 occurs, in the cytoplasm
or the nucleus? Proposed models of TGF-b signaling
pathways have positioned the Smad phosphatases in
the nucleus (Inman et al., 2002; Xu et al., 2002). If so,
then the absence of the appropriate phosphatase is
predicted to be associated with strong and persistent
accumulation of nuclear phosphorylated Mad. Instead,
Chen et al. observe punctate, apparently cytoplasmic
phosphorylated Mad at ectopic locations in the Dro-
sophila embryo. The significance of this in vivo phos-
phorylated Mad staining remains to be determined. Fi-
nally, it is clear that PDP has no activity on the TGF-b/
Nodal activated Smads, Smad2 and Smad3. The identi-
fication of the phosphatase(s) that dephosphorylate
them is eagerly awaited.
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